Trulicity — Class II drug recall D-0883-2022
Completed recall by Cardinal Health Inc., reported 2022-05-25, distributed in NM. TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions du
| Recall number | D-0883-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cardinal Health Inc., Dublin, OH, United States |
| Recall initiated | 2022-04-05 |
| Classified | 2022-05-19 |
| Reported by FDA | 2022-05-25 |
| Distributed | NM |
| Quantity | 1 boxes |
| Reason classes | labeling, temperature control |
| NDC | 00002-1434-80 |
| Lot numbers | D482749A |
| Expiration dates | 2023-10-15 |
Product
Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80
Reason for recall
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0883-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.